OptimizeRx Corp. (NASDAQ: OPRX), a healthcare technology company that provides digital solutions for life sciences companies, announced it has secured a $35 million senior secured credit facility with Fifth Third Bank. The facility comprises a $25 million term loan and a $10 million revolving credit facility, which was undrawn at the time of closing. Roth Capital Partners served as financial advisor for the transaction.
The new credit facility provides OptimizeRx with additional financial flexibility to support its growth strategy. The company specializes in AI-driven tools such as the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT), which enable life science brands to deliver hyper-local, timely engagement with healthcare providers and patients. By bridging healthcare professional and direct-to-consumer strategies, OptimizeRx aims to drive faster treatment decisions and improve patient outcomes.
This capital infusion comes at a time when the healthcare technology sector is seeing increased demand for digital engagement solutions. The funds could be used to accelerate product development, expand market reach, or pursue strategic acquisitions. The company’s focus on privacy-safe, patient-centric technology aligns with industry trends toward personalized medicine and value-based care.
For the pharmaceutical and life sciences industry, OptimizeRx’s enhanced financial capacity may lead to more robust digital marketing and patient engagement tools. This could benefit both drug manufacturers and patients by improving the efficiency of treatment initiation and adherence. The partnership with Fifth Third Bank, a major financial institution, also signals confidence in OptimizeRx’s business model and growth prospects.
The announcement may be significant for investors monitoring the healthcare technology space. A stronger balance sheet could support long-term shareholder value, though the terms of the credit facility, including interest rates and covenants, were not disclosed. The revolving credit facility provides additional liquidity for working capital and other corporate purposes.
OptimizeRx is headquartered in Waltham, Massachusetts, and partners with leading pharmaceutical and life sciences companies. The full announcement is available at https://ibn.fm/G0Fj3.
